Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The lowest quartile of plasma 25(OH)D compared with the highest, had a multivariate OR of 0.63 (95% CI, 0.48 to 0.82) for CRC.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Double-blind reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The Physicians' Health Study was a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene for the primary prevention of cancer and cardiovascular disease among 22,071 U.S.

Source: Methods.

The Physicians' Health Study was a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene for the primary prevention of cancer and cardiovascular disease among 22,071 U.S.

Source: Methods.

This study was approved by the Human Subjects Committee at Brigham and Women's Hospital and the Harvard School of Public Health in Boston, MA, USA.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Joint Effects of Colorectal Cancer Susceptibility Loci, Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer

Randomised controlled trial · PLoS ONE · 2014

Original publication title

Joint Effects of Colorectal Cancer Susceptibility Loci, Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer

Linda T. Hiraki; Amit D. Joshi; Kimmie Ng; Charles S. Fuchs; Jing Ma; Aditi Hazra; Ulrike Peters; Elizabeth W. Karlson; Edward Giovannucci; Peter Kraft; Andrew T. Chan

© 2014 Hiraki et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We did not observe evidence for the modification of genetic susceptibility for CRC according to vitamin D status, or evidence that the effect of common CRC risk alleles differed according to their proximity to putative VDR binding sites.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Genome wide association studies (GWAS) have identified several SNPs associated with colorectal cancer (CRC) susceptibility. Vitamin D is also inversely associated with CRC risk.

Source: Background

Abstract: What methods does the paper describe?

We examined main and joint effects of previously GWAS identified genetic markers of CRC and plasma 25-hydroxyvitamin D (25(OH)D) on CRC risk in three prospective cohorts: the Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), and the Physicians' Health Study (PHS). We included 1895 CRC cases and 2806 controls with genomic DNA. We calculated odds ratios and 95% confidence intervals for CRC associated with additive genetic risk scores (GRSs) comprised of all CRC SNPs and subsets of these SNPs based on proximity to regions of increased vitamin D receptor binding to vitamin D response elements (VDREs), based on published ChiP-seq data.

Among a subset of subjects with additional prediagnostic 25(OH)D we tested multiplicative interactions between plasma 25(OH)D and GRS's. We used fixed effects models to meta-analyze the three cohorts.

Source: Methods

Abstract: Results

The per allele multivariate OR was 1.12 (95% CI, 1.06 to 1.19) for GRS-proximalVDRE; and 1.10 (95% CI, 1.06 to 1.14) for GRS-nonproxVDRE. The lowest quartile of plasma 25(OH)D compared with the highest, had a multivariate OR of 0.63 (95% CI, 0.48 to 0.82) for CRC. We did not observe any significant interactions between any GRSs and plasma 25(OH)D.

Source: Results

Abstract: Conclusions

We did not observe evidence for the modification of genetic susceptibility for CRC according to vitamin D status, or evidence that the effect of common CRC risk alleles differed according to their proximity to putative VDR binding sites.

Source: Conclusions
Authors’ abstract

Background

Genome wide association studies (GWAS) have identified several SNPs associated with colorectal cancer (CRC) susceptibility. Vitamin D is also inversely associated with CRC risk.

Methods

We examined main and joint effects of previously GWAS identified genetic markers of CRC and plasma 25-hydroxyvitamin D (25(OH)D) on CRC risk in three prospective cohorts: the Nurses' Health Study (NHS), the Health Professionals Follow-up Study (HPFS), and the Physicians' Health Study (PHS). We included 1895 CRC cases and 2806 controls with genomic DNA. We calculated odds ratios and 95% confidence intervals for CRC associated with additive genetic risk scores (GRSs) comprised of all CRC SNPs and subsets of these SNPs based on proximity to regions of increased vitamin D receptor binding to vitamin D response elements (VDREs), based on published ChiP-seq data.

Among a subset of subjects with additional prediagnostic 25(OH)D we tested multiplicative interactions between plasma 25(OH)D and GRS's. We used fixed effects models to meta-analyze the three cohorts.

Results

The per allele multivariate OR was 1.12 (95% CI, 1.06 to 1.19) for GRS-proximalVDRE; and 1.10 (95% CI, 1.06 to 1.14) for GRS-nonproxVDRE. The lowest quartile of plasma 25(OH)D compared with the highest, had a multivariate OR of 0.63 (95% CI, 0.48 to 0.82) for CRC. We did not observe any significant interactions between any GRSs and plasma 25(OH)D.

Conclusions

We did not observe evidence for the modification of genetic susceptibility for CRC according to vitamin D status, or evidence that the effect of common CRC risk alleles differed according to their proximity to putative VDR binding sites.

Publication and source details

Original title: Joint Effects of Colorectal Cancer Susceptibility Loci, Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer

Linda T. Hiraki; Amit D. Joshi; Kimmie Ng; Charles S. Fuchs; Jing Ma; Aditi Hazra; Ulrike Peters; Elizabeth W. Karlson; Edward Giovannucci; Peter Kraft; Andrew T. Chan

PLoS ONE · 2014

* E-mail: ACHAN@partners.org

Competing Interests: The authors have declared that no competing interests exist.

Conceived and designed the experiments: LH AJ PK AC. Performed the experiments: LH AJ. Analyzed the data: LH AJ PK AC. Contributed reagents/materials/analysis tools: LH AJ KN CF JM AH UP EK EG PK AC. Wrote the paper: LH AJ KN CF JM AH UP EK EG PK AC.

© 2014 Hiraki et al2014Hiraki et alhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.Support was provided by National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088; R01 CA059045; R01 CA137178; K24 DK098311). Dr. Hiraki was supported by a Canadian Institute of Health Research (CIHR) Fellowship Award. Dr. Ng was supported by an NIH 5K07CA148894 award. Dr. Chan is a Damon Runyon Clinical Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T12:03:03.070848+00:00

DOI: 10.1371/journal.pone.0092212 · PMC3966783